Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sarah V Abelev"'
Autor:
Llewellyn Mills, Jonathon C. Arnold, Anastasia Suraev, Sarah V. Abelev, Cilla Zhou, Thomas R. Arkell, Iain S. McGregor, Nicholas Lintzeris
Publikováno v:
Harm Reduction Journal, Vol 21, Iss 1, Pp 1-11 (2024)
Abstract Background Cannabis was legalised for medical purposes in 2016. Uptake was initially slow, but since 2019 there has been a large increase in the number of Australians who have been prescribed cannabis for medical reasons. Yet a significant n
Externí odkaz:
https://doaj.org/article/0b5443fc3a3644e29a06d111006efdac
Autor:
Thomas R. Arkell, Sarah V. Abelev, Llewellyn Mills, Anastasia Suraev, Jonathon C. Arnold, Nicholas Lintzeris, Iain S. McGregor
Publikováno v:
Journal of Cannabis Research, Vol 5, Iss 1, Pp 1-10 (2023)
Abstract Road safety is an important concern amidst expanding worldwide access to legal cannabis. The present study reports on the driving-related subsection of the Cannabis as Medicine Survey 2020 (CAMS-20) which surveyed driving-related behaviors,
Externí odkaz:
https://doaj.org/article/24b7500f626c40bd959a25d4860958d3
Autor:
Nicholas Lintzeris, Llewellyn Mills, Sarah V. Abelev, Anastasia Suraev, Jonathon C. Arnold, Iain S. McGregor
Publikováno v:
Harm Reduction Journal, Vol 19, Iss 1, Pp 1-10 (2022)
Abstract Background Australia has had a framework for legal medicinal cannabis since 2016, yet prior online surveys in 2016 and 2018 indicated that most consumers continued to use illicit medical cannabis products. Regulatory data indicate an increas
Externí odkaz:
https://doaj.org/article/8cd72144e6574398a272247afaf49db0
Autor:
Anastasia Suraev, Llewellyn Mills, Sarah V Abelev, Thomas R Arkell, Nicholas Lintzeris, Iain S McGregor
Publikováno v:
Nature and Science of Sleep. 15:245-255
Anastasia Suraev,1â 3 Llewellyn Mills,4,5 Sarah V Abelev,1 Thomas R Arkell,6 Nicholas Lintzeris,4,5,* Iain S McGregor1â 3,* 1The University of Sydney, Lambert Initiative for Cannabinoid Therapeutics, Sydney, NSW, Australia; 2The Uni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a885f088c3e3edf887702172861abb9b
https://doi.org/10.2147/nss.s390583
https://doi.org/10.2147/nss.s390583
Autor:
Crispin Corte, Anastasia S. Suraev, Susan J. Connor, Sarah V. Abelev, Lucy K Gold, Iain S. McGregor, Melissa J. Benson, Lewis J. Martin
Publikováno v:
Crohn's & Colitis 360. 2
Background Medicinal cannabis (MC) is an increasingly utilized treatment option for various refractory diseases. While robust clinical evidence supporting MC efficacy in inflammatory bowel disease (IBD) is lacking, many IBD patients report using MC t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a8164096cbabbb16b8c4fd01b7fc71e
https://doi.org/10.1093/crocol/otaa015
https://doi.org/10.1093/crocol/otaa015
Publikováno v:
Crohn's & Colitis 360. 2
Background Medicinal cannabis (MC) is being used for symptomatic relief by many patients with inflammatory bowel disease (IBD), often independently of clinical guidance. Such use presents challenges for supporting clinicians. The aim of this study wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53faa1e37df6d94d4e1c658a5d6b2918
https://doi.org/10.1093/crocol/otaa045
https://doi.org/10.1093/crocol/otaa045
Autor:
Jonathon C. Arnold, Rhys Cohen, DG Couch, Elizabeth A. Cairns, Sarah V. Abelev, Mat Henderson, Natalie Gauld, Iain S. McGregor
Publikováno v:
The International journal on drug policy. 85
Background Recent legislative change has allowed increased access to cannabis products in many jurisdictions. In some locations, this includes over-the-counter (OTC) and/or online access to products containing cannabidiol (CBD), a non-intoxicating ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea89265d2e550eb20a108cab5aa47351
https://pubmed.ncbi.nlm.nih.gov/32919298
https://pubmed.ncbi.nlm.nih.gov/32919298
Autor:
Peter T. Doohan, Mary Chebib, Sarah V. Abelev, Lyndsey L. Anderson, Nathan L. Absalom, Iain S. McGregor, Jonathon C. Arnold, Lewis J. Martin, Ivan K. Low
Publikováno v:
Epilepsia. 60(11)
Objective Cannabidiol (CBD) has been approved by the US Food and Drug Administration (FDA) to treat intractable childhood epilepsies, such as Dravet syndrome and Lennox-Gastaut syndrome. However, the intrinsic anticonvulsant activity of CBD has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fef46dc36e622cee96587c79742ed290
https://pubmed.ncbi.nlm.nih.gov/33460074
https://pubmed.ncbi.nlm.nih.gov/33460074
Autor:
Kristie Leigh Smith, Cilla Zhou, Michael Kuligowski, Jonathon C. Arnold, Natalia I. Brzozowska, David J. Clarke, Ligia Menezes Cavalcante, Sarah V. Abelev, Stephanie M. Todd, Peter M. Waters
Publikováno v:
Brain, behavior, and immunity. 65
P-glycoprotein (P-gp) is an ABC transporter expressed at the blood brain barrier and regulates the brain uptake of various xenobiotics and endogenous mediators including glucocorticoid hormones which are critically important to the stress response. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7e832fc46644f46a6594736b2a61860
https://pubmed.ncbi.nlm.nih.gov/28502879
https://pubmed.ncbi.nlm.nih.gov/28502879